Skip to content
Clinical Trials – home
LuxembourgBack to Luxembourg

Clinical trials in Libramont-Chevigny

19 clinical trials in Libramont-Chevigny, Luxembourg. Every trial is listed in the EU Clinical Trials Register and updated daily.

Libramont-Chevigny at a glance
19
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

19 trials in Libramont-Chevigny

Open in trial search
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:AstraZeneca AB
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Capivasertib
  • Sponsor:Relay Therapeutics Inc.
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:AstraZeneca AB
Countries:LuxembourgLuxembourg
  • Participants:65+ years
  • Substances:Capecitabine
  • Sponsor:Institut Jules Bordet
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Regn7508
  • Sponsor:Regeneron Pharmaceuticals Inc.
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Macrogenics Inc.
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Macrogenics Inc.
Registered drug
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Pharmacosmos A/S
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Brimonidine Tartrate
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Camizestrant
  • Sponsor:AstraZeneca AB

Neoplasm

Not recruiting
Registered drugNo placebo
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Df1001
  • Sponsor:Dragonfly Therapeutics Inc.
Registered drug
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Panbela Therapeutics Inc.

Other cities in Luxembourg

The busiest research cities in the country

All 2 cities in Luxembourg

Clinical research in Libramont-Chevigny

What the registry says about research in the country

01 Breast Cancer Research

Multiple clinical trials focusing on advanced breast cancer treatments, particularly for patients with different receptor statuses including HER2-negative and hormone receptor-positive cases. Studies evaluate novel therapeutic combinations and treatment approaches.

  • Hormone receptor-positive treatments
  • Triple-negative breast cancer therapies
  • Combination therapy approaches
02 Lung Cancer Studies

Innovative research exploring non-small cell lung cancer treatments and new therapeutic options for extensive-stage small cell lung cancer. Trials evaluate various treatment combinations and compare effectiveness with standard therapies.

  • Advanced NSCLC treatments
  • Immunotherapy combinations
  • Novel therapeutic approaches
03 Gynecological Oncology

Comprehensive studies investigating treatments for various gynecological cancers, including endometrial, ovarian, and fallopian tube cancers. Research focuses on combining immunotherapy with standard treatments.

  • Endometrial cancer therapies
  • Ovarian cancer treatments
  • Advanced peritoneal cancer approaches
04 Urological Cancer Research

Clinical trials examining new treatments for bladder cancer and prostate cancer, including studies of innovative therapeutic combinations and maintenance therapies.

  • Non-muscle invasive bladder cancer
  • Metastatic prostate cancer
  • Novel combination approaches
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.